Literature DB >> 8135314

Pneumonia in the surgical intensive care unit: factors determining successful outcome.

M A Malangoni1, R Crafton, F C Mocek.   

Abstract

A review of 85 consecutive patients who acquired pneumonia in a surgical intensive care unit revealed several parameters associated with successful treatment. Fifty-five patients (65%) recovered after a single course of antimicrobial therapy. Statistical analysis demonstrated significant differences between those treated successfully and those whose therapy failed during the duration of intubation (7.2 +/- 1.5 days versus 29.3 +/- 4.3 days), duration of ventilation (6.7 +/- 1.4 days versus 14.8 +/- 3.2 days), and the alveolar-arterial oxygen gradient on the day of diagnosis (215 +/- 23 mm Hg versus 343 +/- 33 mm Hg, all p < 0.01). Multiple antimicrobial resistance was uncommon in bacteria isolated on initial culture but occurred in two thirds of patients with treatment failures. Pneumonia due to Pseudomonas aeruginosa and Staphylococcus aureus were associated with the highest rate of treatment failure, which were 56% and 45%, respectively.

Entities:  

Mesh:

Year:  1994        PMID: 8135314     DOI: 10.1016/0002-9610(94)90086-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

1.  Utility of Gram's stain and efficacy of quantitative cultures for posttraumatic pneumonia: a prospective study.

Authors:  M A Croce; T C Fabian; L Waddle-Smith; S M Melton; G Minard; K A Kudsk; F E Pritchard
Journal:  Ann Surg       Date:  1998-05       Impact factor: 12.969

2.  Intercurrent complications in chronic alcoholic men admitted to the intensive care unit following trauma.

Authors:  C D Spies; B Neuner; T Neumann; S Blum; C Müller; H Rommelspacher; A Rieger; C Sanft; M Specht; L Hannemann; H W Striebel; W Schaffartzik
Journal:  Intensive Care Med       Date:  1996-04       Impact factor: 17.440

3.  Discovery of bacterial fatty acid synthase type II inhibitors using a novel cellular bioluminescent reporter assay.

Authors:  Joselynn Wallace; Nicholas O Bowlin; Debra M Mills; Panatda Saenkham; Steven M Kwasny; Timothy J Opperman; John D Williams; Charles O Rock; Terry L Bowlin; Donald T Moir
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

4.  Effector ExoU from the type III secretion system is an important modulator of gene expression in lung epithelial cells in response to Pseudomonas aeruginosa infection.

Authors:  B McMorran; L Town; E Costelloe; J Palmer; J Engel; D Hume; B Wainwright
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

5.  Intoxication of host cells by the T3SS phospholipase ExoU: PI(4,5)P2-associated, cytoskeletal collapse and late phase membrane blebbing.

Authors:  Hiromi Sato; Dara W Frank
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.